Authors: Chan, P-C.1; Chang, L-Y.2; Wu, Y-C.3; Lu, C-Y.i.2; Kuo, H-S.3; Lee, C-Y.2; Huang, L-M.2; Chen, C-J.4

Source: The International Journal of Tuberculosis and Lung Disease, Volume 12, Number 12, December 2008 , pp. 1401-1406(6)

Publisher: International Union Against Tuberculosis and Lung Disease

Abstract:

OBJECTIVE: To evaluate the effect of neonatal vaccination with bacille Calmette-Guérin (BCG) on tuberculin skin test (TST) reactivity over time and to define the optimal age-specific induration cut-offs to detect latent tuberculosis infection (LTBI).

DESIGN: TSTs were performed on 783 children aged 3 months to 14 years who had received neonatal BCG. The estimated annual risk of LTBI was derived from TSTs administered to 2504 children aged 7 years who lacked BCG scars. Goodness-of-fit analysis was used to determine the optimal age-specific cut-off values.

RESULTS: The effect of neonatal BCG on TST induration waned with age, reaching a nadir at age 6-7 years. This was followed by a rise in TST reactivity. The optimal age-specific TST cut-off values for the detection of LTBI was estimated to be respectively 21, 18, 13 and 10 mm at ages 0-1, 2-3, 4-5 and 6-7 years. There was a close correlation between these new cut-off values with the estimated risk of LTBI for the first 7 years of life (r = 0.93, P < 0.001).

CONCLUSIONS: The effect of neonatal BCG on TST gradually declines over the first 7 years of life. Our proposed new age-specific TST induration cut-off values could help differentiate between response to BCG and LTBI in young children. 
Keywords: tuberculin skin test; BCG; infants and children; latent tuberculosis infection

Document Type: Regular paper

Affiliations: 1: Centers for Disease Control, Department of Health, Taipei, Taiwan; Graduate Institute of Epidemiology, National Taiwan University, Taipei, Taiwan; Department of Paediatrics, National Taiwan University Hospital and College of Medicine, National Ta 2: Department of Paediatrics, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei, Taiwan 3: Centers for Disease Control, Department of Health, Taipei, Taiwan 4: Graduate Institute of Epidemiology, National Taiwan University, Taipei, Taiwan; Genomics Research Centre, Academia Sinica, Taipei, Taiwan

Saiba mais em: http://www.ingentaconnect.com/content/iuatld/ijtld/2008/00000012/00000012/art00012

Sobre a REDE-TB

A Rede Brasileira de Pesquisa em Tuberculose (REDE-TB) é uma Organização Não Governamental (ONG) de direito privado sem fins lucrativos, preocupada em auxiliar no desenvolvimento não só de novos medicamentos, novas vacinas, novos testes diagnósticos e novas estratégias de controle de TB, mas também na validação dessas inovações tecnológicas, antes de sua comercialização no país e/ou de sua implementação nos Programa de Controle de TB no País.


bt2

Contato

E-mail: redetb.rp@gmail.com

Tel: +55 (21)3938 - 2426
Tel/ Fax: +55 (21)3938 - 2431.

Endereço: Avenida Carlos Chagas Filho, 791, Cidade Universitária - Ilha do Fundão, Rio de Janeiro, RJ - Brasil. CEP: 21941-904

Assine a newsletter da REDE-TB

Curta REDE-TB no Facebook